Clinical Study

Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease

Figure 3

Serum VEGF and IL-6 level change within 4 weeks after treatment. CD133+ group had a significant increasing VEGF and decreasing IL-6 level than the control since the first week after treatment, and this significance seemed to become weaker from the 4th week after treatment. “∘” represents mild outliers in boxplot, and the small numbers beside it represent the case numbers.